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The development of transgenesis in axolotls is crucial for studying development and regeneration as it would allow for long-term cell fate
tracing as well as gene expression analysis. We demonstrate here that plasmid injection into the one-cell stage axolotl embryo generates mosaic
transgenic animals that display germline transmission of the transgene. The inclusion of SceI meganuclease in the injections (Thermes, V.,
Grabher, C., Ristoratore, F., Bourrat, F., Choulika, A., Wittbrodt, J., Joly, J.S., 2002. I-SceI meganuclease mediates highly efficient transgenesis in
fish. Mech. Dev. 118, 91–98) resulted in a higher percentage of F0 animals displaying strong expression throughout the body. This represents the
first demonstration in the axolotl of germline transmission of a transgene. Using this technique we have generated a germline transgenic animal
expressing GFP ubiquitously in all tissues examined. We have used this animal to study cell fate in the dorsal fin during development. We have
uncovered a contribution of somite cells to dorsal fin mesenchyme in the axolotl, which was previously assumed to derive solely from neural crest.
We have also studied the role of blood during tail regeneration by transplanting the ventral blood-forming region from GFP+ embryos into
unlabeled hosts. During tail regeneration, we do not observe GFP+ cells contributing to muscle or nerve, suggesting that during tail regeneration
blood stem cells do not undergo significant plasticity.
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The production of transgenic animals is a powerful tool used
successfully in many animal systems to study early embryo-
genesis, organogenesis and adult tissues. It is a particularly
important technique for studying regeneration, as it would
allow for long-term cell fate tracing, as well as gene expression
analysis, two important aspects of understanding regeneration
on a mechanistic level. Vertebrate regeneration is studied in
several different model organisms, including caudata (sala-
manders) such as Ambystoma mexicanum (axolotl), anurans
such as Xenopus laevis, and teleosts such as Danio rerio0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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(E.M. Tanaka).(zebrafish) and Oryzias latipes (medaka). Each of these
systems has distinct features for studying regeneration and
these distinctions make it crucial to have transgenic and
genomic resources available in each of the organisms. For
example, Xenopus is able to regenerate its limbs and tails as a
tadpole but then loses this capacity upon metamorphosis while
salamanders retain the ability to regenerate a wide variety of
tissues and structures including muscle, cartilage, skin, spinal
cord, lens and jaw throughout their lifespan (Goss, 1969). A
number of molecular and cellular aspects of regeneration are
also distinctive. In particular, wider plasticity of cell differen-
tiation is observed during regeneration in caudata such as the
axolotl compared to Xenopus. Implantation and lineage tracing
experiments have shown that in caudates, dedifferentiation of
multinucleated muscle fibers into proliferative mononucleate
cells contributes a significant number of cells to the blastema90 (2006) 386 – 397
www.e
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Furthermore, in vivo tracing of spinal cord cells revealed that
neural progenitors have the potential to switch fate and form
muscle and cartilage during tail regeneration.(Echeverri and
Tanaka, 2002a). Such metaplasia was not observed in Xenopus
cell tracking experiments where each tissue layer exclusively
regenerated itself (Gargioli and Slack, 2004). While teleosts are
able to regenerate their fins and portions of the heart, complete
regeneration of the spinal cord, as observed in axolotls, is not
possible in most teleost species (Kawakami et al., 2004). On a
cellular level the plasticity of cell differentiation during teleost
regeneration has not yet been widely established.
Work in Xenopus laevis provides an excellent example of
how transgenesis can be used for studying regeneration. The
Cre-loxP system was used to trace muscle cell fate during tail
regeneration where it was concluded that muscle fibers do not
dedifferentiate (Gargioli and Slack, 2004; Ryffel et al., 2003).
Gargioli and Slack also grafted embryonic tissue from GFP+
Xenopus embryos into unlabelled hosts to follow the fate of
other tissue types and found no transdifferentiation of spinal
cord and notochord cells during tail regeneration. To address
the molecular pathways involved in initiating regeneration
Beck et al. (2001, 2003) created transgenic animals where key
extracellular and intracellular signaling molecules were under
the control of the Xenopus HSP70 promoter, allowing
induction of gene expression at the time of tail amputation.
This work implicated a role of the Notch and BMP pathways in
induction of tail regeneration. These Xenopus studies illustrate
the value of transgenic approaches for regeneration research.
As the cellular and molecular differences between tail
regeneration in anurans and caudata become more evident, the
significance of studying regeneration in both taxa is becoming
increasingly clear. It is, therefore, of particular importance to
develop transgenic approaches in caudata. Two transgenic
approaches have been described for the newt, Cynops
pyrrhogaster. Makita et al. (1995) found that injection of
fertilized Cynops eggs with a linearized eukaryotic expression
vector containing the lacZ gene resulted in mosaic reporter
gene expression in tailbud stage embryos. The inclusion of
newt satellite 2 sequences in the plasmid augmented the extent
of expression 10-fold, with a widespread distribution of gene
expression in hatching larvae. Germline transmission was not
assessed in these experiments. In a different approach, Ueda et
al. (2005) successfully applied a modification of the Xenopus
transgenic technique involving in vitro fertilization coupled to
sperm injection to produce transgenic Cynops pyrrogaster.
Transgenic animals were generated at a frequency of approx-
imately 2% and displayed uniform transgene expression
throughout the body. Unfortunately, a disadvantage of the
Cynops system is the complex life cycle and long time to
sexual maturity, making propagation of transgenic lines
unwieldy. Furthermore, in the Ueda protocol, a large number
of females were required to produce enough unfertilized eggs
for a single experiment, making the possibility of producing
multiple transgenic lines difficult.
To circumvent these problems, we endeavored to produce
germline transgenic animals in the axolotl (Ambystomamexicanum), a species that is easily bred under laboratory
conditions with a generation time of approximately 1 year.
Another advantage of using axolotls is the availability of
skin pigment mutants such as the white mutant where
pigment cells are inhibited from migrating out laterally
under the epidermis from their neural crest origin on top of
the neural tube (Epperlein and Lofberg, 1990). These
mutants facilitate visualization of lineage tracers such as
GFP in regeneration studies (Echeverri and Tanaka, 2002b,
2003). Our goal was to establish an efficient transgenesis
method for the axolotl that would allow first, production of
a large number of transgenic animals in the F0 generation
and second, germline transmission. Due to the complications
of applying the Xenopus protocol to caudate eggs, described
in Ueda et al. (2005), we chose to test transgenesis
protocols that are widely used in teleosts. Transgenesis in
teleosts is normally achieved via direct injection of plasmid
DNA into the fertilized egg. This results in F0 animals
expressing the transgene in a mosaic fashion, a proportion
of which display germline transmission of the transgene
(Culp et al., 1991; Stuart et al., 1988, 1990). It was recently
reported that coinjection of ISceI meganuclease with
plasmids bearing its recognition sites enhances expression,
decreases mosaicism in the F0 generation, and increases the
germline transmission rate (Thermes et al., 2002). Here, we
describe plasmid injection into the one-cell stage axolotl
embryo as a method of generating transgenic animals and
the evaluation of ISceI meganuclease’s ability to enhance
expression. Using this technique we report for the first time
in the axolotl germline transmission of a transgene in a
Mendelian ratio.
The availability of a GFP transgenic animal is a valuable
reagent for cell tracking experiments, since it provides an
indelible marking system with high spatial resolution that is
visible in live animals. These animals provide a transplanta-
tion system comparable to the valuable quail-chick chimeras,
which have been crucial for studying cell fate during avian
embryogenesis and organogenesis (Le Douarin and Kalcheim,
1999). The axolotl is a particularly good system for tracking
cell fate by transplanting tissues from a GFP+ animal into
unlabeled hosts due to its unrivaled accessibility for tissue
engraftment at any stage of its lifecycle. The transplantation
of GFP+ cells circumvents the problems of other labeling
techniques such as DiI, where the possibility of the dye
spreading to unwanted cells always exists, or mRNA/dextran
injection and electroporation which are relatively transient
markers that are diluted out upon cell division. Here, we use
embryonic tissue grafting to study two essential problems in
development and regeneration. By transplantation of neural
folds and somites, we demonstrate that the dorsal fin
mesenchyme, which was originally assumed to derive entirely
from neural crest (see Tucker and Slack, 2004), has a dual
origin; deriving from both neural crest and from somites.
Second, we examine the issue of hematopoietic cell plasticity
and its contribution to regeneration. Recent reports of
hematopoietic cells being able to contribute to other tissue
lineages such as muscle or brain in the mouse have raised
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2002; Ferrari et al., 1998; Mezey et al., 2000). The frequency
of such events, as well as their potential relevance to tissue
regeneration is still open to question. We wanted to test
whether blood cells display widespread plasticity during
axolotl tail regeneration—namely whether blood cells con-
tribute significantly to muscle and central nervous system.
Here we do not observe blood cells contributing to muscle or
central nervous system during tail regeneration, indicating that
hematopoetic cell plasticity is not an ubiquitous mechanism
used during regeneration.
Materials and methods
Animal care, embryo handling and injection protocol
All axolotls were bred and raised in the laboratory. In all experiments, white
mutant (d/d) axolotls were used. Axolotls were staged according to the normal
tables from (Bordzilovskaya et al., 1989). In all injection experiments embryos
were used at the one-cell stage. Embryos were collected in the morning and kept
in tap water at 4-C until the time of injection to assure they remained at the one-
cell stage. All embryos were dejellied manually with fine forceps (Dumont 5,
Fine Science Tools, Germany) and kept in 1 MMR with penicillin –
streptomycin (Invitrogen GmbH, Germany). Our experience in embryo handling
allows us to say that careful manual dejellying does not harm embryos and has
very little effect on survival. However, since different spawns of embryos had
differing survival rates, one part of each spawn was left as a quality and viability
control. Control, non-dejellied, embryos were kept in aerated water.
Prior to injection embryos were transferred to chilled 20% Ficoll/1MMR/
pen-strep. (Ficoll obtained from Sigma, Germany). Injections were performed
at the one-cell stage (at 22-C, the time from fertilization to the first division is 6
h; (Bordzilovskaya et al., 1989). Injections were performed using a pressure
injector Picospritzer II (Parker Instrumentation) mounted alongside of an
Olympus Stereo SZX12 dissecting microscope. Glass capillary needles were
prepared on a Flaming/Brown micropipette puller; model P-97, (Sutter
Instruments Co., USA). Needles were back-filled with DNA alone or DNA +
ISceI Enzyme (DNA: 0.1 Ag/Al or 0.01 Ag/Al; ISceI enzyme: 1 U/Al; 1
meganuclease buffer. Enzyme and buffer were obtained from New England
Biolabs, USA). 10 nl of solution was injected into the one-cell stage embryo.
The optimal injection volume of 10 nl was established by a series of plasmid
injections in the range of volumes from 30 nl to 5 nl. A volume of 20 nl can be
used, however it may result in a lower survival rate of embryos depending on
their quality. After injection embryos were kept in 20% Ficoll/1 MMR
solution for 2–3 h to prevent yolk leakage and then were transferred to 5%
Ficoll/0.1 MMR/pen-strep and left in this solution overnight. Finally,
embryos were transferred to 0.1 MMR/pen-strep, until the hatching stage,
when animals were kept in aerated tap water at room temperature. All solutions
used for injections and embryo rearing were 0.22 Am filtered.
Grafting GFP+ neural folds and somites
Before being used for grafting white mutant (d/d) GFP+ donor embryos and
white hosts were washed thoroughly with tap water and sterile Steinberg solution
(Steinberg, 1975) containing antibiotics. They were then decapsulated manually.
For grafting GFP+ trunk neural fold material or somites, GFP+ donors and hosts
were placed into the depression of an agar dish filled with cold Steinberg saline.
Grafting was performed under sterile conditions using tungsten needles.
Neural folds
Neural folds containing cranial and trunk regions (n = 2), or one complete
left trunk neural fold (n = 8) were grafted orthotopically from white GFP+
transgenic neurulae (stages 15–17) into white mutant hosts from which neural
fold material of equivalent size had been extirpated. Two to 4 days after the
operation the distribution of GFP+ cells in the hosts was followed under
fluorescence optics.Somites
For grafting single somites, the epidermis was lifted from the left
dorsolateral midtrunk of white GFP+ transgenic embryos (stages 23/24). One
somite was extirpated and implanted into a similar site of a white host where a
somite had been removed. The epidermis was then folded back over the
implanted somite and pressed against it with a small glass disc for a few
minutes. Migration of GFP+ cells into the dorsal fin was followed under
fluorescence optics.
Histology and immunofluorescence
Several days after grafting GFP+ tissues larvae were anaesthetized with MS
222 (Serva) and fixed with 4% paraformaldehyde (PFA) in 0.1 M PBS
overnight. Fixed specimens were washed and transverse vibratome sections
(100 Am) were cut on a vibratome series 1000 sectioning system (Ted Pella,
Inc.) in order to investigate the internal distribution of GFP+ cells. Some PFA-
fixed larvae of similar age as larvae with GFP+ somites (stage 38) were
embedded in paraffin (Leica ASP 300) for investigating the distribution of
PAX7 positive dermatome cells on transverse sections (5 Am). Microwaved
transverse sections (5 Am) were stained with a primary PAX7 antibody (DSHB)
and with biotinylated secondary antibodies and tertiary streptavidin–peroxi-
dase complexes (Vectastain ABC-Elite-Kit).
In the samples for characterizing the fully GFP transgenic animal, 5-day
blastemas of GFP+ juveniles were fixed in 4% PFA overnight at 4-C, washed
3  15 min with PBS at room temperature and placed in 30% sucrose in PBS
overnight at 4-C. Tails were mounted in Tissue Tek (Sakura) and cryosections
(10 Am) were collected on Histobond Adhesion microslides (Marienfeld,
Germany). To visualize the structure of the tissues, sections were stained with a
hematoxylin solution (Sigma, Germany) for 20 s and washed extensively with
tap water, followed by a 3-min wash in PBS. Nuclei were stained for 8 min with
Hoechst followed by 3  5 min washes in PBS. Slides were mounted using
Mowiol and allowed to dry over night.
Microscopy
For transgene expression analysis animals were anesthetized with
0.001% ethyl-p-aminobenzoate (Sigma, Germany), placed on a coverslip
and imaged using a 10 Plan-Neofluor objective on a Zeiss Axiovert 2
microscope with a CCD camera (Diagnostic Instruments, USA) controlled
by a Metamorph image acquisition system (Visitron). For imaging of
dissected GFP+ organs and tissues we used an Olympus Stereo SZX12
microscope with fluorescence attachment controlled by Diagnostic Instru-
ments software (USA). Sections of GFP+ tissues from transgenic GFP
animals were imaged on an Olympus BX61 microscope using brightfield
and fluorescence optics.
Plasmid constructs
Plasmid constructs used in experiments were: pCSKA-hGFP-SceI (5.0 kb)
(kindly provided by C. Grabher) that contains the Xenopus borealis
cytoskeleton actin promoter driving hGFP flanked by SceI sites. CMVGFP3-
ITR (5.3 kb). pCS2nhgalITR was digested with HindIII and XhoI to remove
the lacZ sequence, which was replaced by the GFP3 sequence obtained after
HindIII/XhoI digestion of XCarGFP3ITR. GFP3 is a version of GFP that was
mutated for better expression in Xenopus (both plasmids used for this
cloning—kind gift from Sylvia Evans).
pCAGGsEGFP(Sce) (5.9 kb) was constructed by insertion of two
oligonucleotides containing ISceI recognition sequences in opposite orienta-
tions flanking the pCAGGsEGFP cassette that contains EGFP driven by
chicken h-actin promoter with CMV-IE (CAGGsEGFP plasmid kindly
provided by F. Stewart).
Plasmids were purified using MaxiPrep Kits (Quiagen, Germany)
(pCSKA-hGFP-SceI, pCAGGsEGFP(SceF) and CMVGFP3-ITR), EndoFree
Quiagen Kit (pCAGGsEGFP and pCAGGsEGFP(Sce)) and cesium chloride
preparation (pCAGGsEGFP(Sce)). The type of plasmid purification in
meganuclease injections did not seem to have a significant influence on
expression or survival.
Table 1
Comparison of expression levels, duration of expression and survival rate of animals injected with three different promoters: CMV—cytomegalovirus promoter,
CSKA—X. borealis cytoskeletal actin promoter, CAGGs—chicken b-actin promoter combined with IE CMV enhancer
Promoter Survived/
injected (%)
Rate of expression
% (No.)
Categories of expression at
hatchling
Duration and intensity of EGFP
expression in time
Very strong
No./% survivors
Strong No./%
survivors
Moderate No./%
survivors
Weak No./%
survivors
Embryo Hatchling Larvae
(2 months)
CMV 113/639 (18) 34% (38) 38 (100) ++ + 
CSKA 10/180 (6) 50% (5) 2 (40) 3 (60) ++ + +
CAGGs 6/51 (12) 100% (6) 1 (17) 5 (83) +++ +++ +++
Fig. 1. Axolotl injected with CAGGsEGFP construct—founder animal of our
first transgenic line of axolotl. CAGGs—chicken B-actin + IE CMV promoter.
(A) Expression of EGFP after 1 month. The animal is about 1.2 cm long. (B)
Expression of EGFP in the same animal after 6 months. The animal is about 13
cm long. Expression at this level was observed until the first mating. (C) F1
animals derived from mating of the GFP+ axolotl. Progeny are at the 2-cm-long
larval stage. GFP is ubiquitously expressed all over the body.
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stored at 80-C and used according to the teleost protocol available by
personal communication with Jochen Wittbrodt and Clemens Grabher
(Jochen.Wittbrodt@EMBL.de or Clemens.Grabher@EMBL.de).
Results
Plasmid injection results in mosaic transgene expression with
the duration of expression being promoter dependent
To assess the efficacy of plasmid injection for generating
stable transgene expression, we tested plasmids harboring three
different constitutive promoters driving green fluorescent
protein: cytomegalovirus (CMVGFP), X borealis cytoskeletal
actin (CSKAhGFP; Thermes et al., 2002), and cytoplasmic
actin fused to the CMV enhancer, (CAGGsEGFP; Niwa et al.,
1991). In this experiment we injected 2 ng of DNA/egg. All
plasmids yielded mosaic expression of fluorescent protein in
the developing embryos ranging from the labeling of an
occasional cell, to animals where at least 50% of the body cells
expressed the transgene.
To evaluate and compare the extent of mosaicism and
intensity of expression we categorized the hatchlings into four
expression categories (Table 1). ‘‘Very strong’’ indicated
animals that displayed almost ubiquitous expression of GFP
so that under the stereomicroscope the intensity of fluorescence
was relatively uniform and distinct patches of cells were not
visible. The ‘‘strong’’ category denoted animals where expres-
sion was widespread and strong, but some mosaicism was
evident, with clearly visible patches of muscle, skin, heart,
blood cells, veins, neural system and notochord. ‘‘Moderate’’
denoted animals with a weaker intensity of fluorescence in
greater than 50% of the cells or animals with a higher intensity
of fluorescence in slightly less than 50% of cells. Such animals
typically expressed the reporter gene mostly in body muscles
and skin and with very few blood cells and heart labeled. The
‘‘weak’’ category represented weak expression of reported gene
and was mostly limited to small patches of body muscles and
scattered patches of skin. From these observations it was clear
that the intensity and extent of expression was promoter
dependent (Table 1).
Significantly, the different promoters showed widely
different persistence of expression over the course of
development. The expression driven by the CMV promoter
decreased steeply over time to the stage where all animals
lost most of the fluorescent labeling by 2 months and only
small, scattered groups of muscle or skin cells continued toexpress label (Table 1). The CSKA promoter, although a
cellular promoter, was also mildly silenced over time. In
contrast, the expression obtained from the CAGGs promoter
was strong and most importantly this strong expression
persisted beyond 6 months (Figs. 1A and B). The one F0
male that displayed ‘‘very strong’’ GFP expression in close
to all cells of the body was grown for 14 months to sexual
maturity. Expression of GFP was stable throughout devel-
opment and into adulthood (Figs. 1A and B). Considering
the persistence of the CAGGs-driven expression, it is likely
that the CMV-driven construct is silenced in the genome
over time. Indeed delivery of CMV promoter driven
constructs into rat muscle via adenovirus injection is
extensively silenced soon after delivery to the cell (Brooks
et al., 2004). Silencing of CMV-promoter driven gene
expression has also been described in transgenic Xenopus
(Ryffel et al., 2003). In contrast the CAGGs promoter has
been used for widespread expression in transgenic mice (for
Table 2
Embryos at one-cell stage were injected with various combinations of plasmid and I-SceI enzyme
Construct Injected
No.
Survived
No./%
Very strong
No./% survivors
Strong No./%
survivors
Moderate No./%
survivors
Weak No./%
survivors
CAGGS GFP SCE + E 281 92 (33%) 15 (16%) 9 (10%) 31 (34%) 37 (40%)
CAGGS GFP SCE 157 74 (47%) 0 8 (11%) 23 (31%) 43 (58%)
CAGGS GFP + E 291 68 (23%) 0 3 (4%) 9 (13%) 56 (82%)
CAGGS GFP 223 61 (27%) 1 (2%) 3 (5%) 14 (23%) 43 (70%)
E 155 103 (66%)
The quality of expression was checked after 1.5 months and animals were classified in categories of expression described in the text; E—I-SceI meganuclease
enzyme.
Table 3
Germline transmission of pCAGGseGFP
Animal Sex (M/F) No of
EGFP+
embryos
No of
EGFP
embryos
% embryos
GFP+
1 (very strong) M 160 150 52
2 F 159 213 43
3 F 0 150 0
4 F 0 183 0
5 F 10 163 6
6 M 3 311 1
7 F 0 46 0
8 M 0 62 0
9 F 0 207 0
10 M 0 175 0
11 F 8 493 1
12 F 0 59 0
13 F 0 80 0
14 M 40 152 21
15 M 0 243 0
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effectiveness in promoting ubiquitous expression in trans-
genic animals.
Coinjection of ISceI meganuclease enzyme with a plasmid
containing its recognition sites enhances transgene expression
One goal was to develop a transgenesis method where we
could produce relatively large numbers of animals with the
least mosaicism possible in the F0 generation so that the F0
animals might be used directly in cell tracking experiments, as
is done in Xenopus. A second consideration was germline
transmission of the transgene. To reduce mosaicism in the F0
generation and to increase the chance of germline transmission
we tested a method successfully implemented in medaka
involving coinjection of ISceI enzyme mixed with plasmid
containing its recognition sites (Thermes et al., 2002). ISceI
meganuclease is an intron-encoded homing endonuclease with
an 18 bp long recognition sites that was isolated from S.
cerevisiae (Jacquier and Dujon, 1985). The meganuclease
enzyme induces double stranded break formation at its
recognition sites and probably also takes part in double strand
break repair (Rouet et al., 1994).
To test whether the ISceI method alleviates mosaicism, we
constructed a pCAGGs-EGFP plasmid where SceI sites flanked
the expression cassette and injected the pCAGGsEGFP(Sce)
and pCAGGsEGFP plasmids with and without enzyme. In
initial experiments we tested optimal plasmid and enzyme
concentrations by a series of plasmid injections in the range
from 2 ng to 500 pg per embryo. Optimal results were obtained
with injection of 1 ng of plasmid per embryo. With this amount
of plasmid the optimal enzyme amount was established by
series of injections where the enzyme concentration was varied
from 0.01 to 4 U/Al. 1 U/Al (10 nU/embryo) of enzyme in the
injection mix yielded optimal results. Co-injection of pCAGG-
sEGFP(Sce) with the ISceI enzyme resulted in 16% of animals
classified as ‘‘very strong’’ (Sup. Fig. 1) in comparison to the
control injections where only 2% of animals were in this class
(Table 2).
Germline transmission of transgene expression
To evaluate germline transmission we raised 15 F0 animals
harboring the pCAGGsGFP plasmid to adulthood and per-
formed matings with the white mutant. This experiment was
performed prior to obtaining the animals from the meganu-clease experiments described above. Therefore, the animals
used for mating represented one male with ‘‘very strong’’
expression, and 14 animals with ‘‘moderate or strong’’
expression (Sup. Fig. 1). In such matings, 6 out of 15 animals
produced at least some GFP+ embryos in the F1 generation,
with 3 animals generating over 20% GFP+ eggs (Table 3 and
Sup. Fig. 1).
Notably, the mating of the ‘‘very strong’’ male depicted in
Fig. 1 with a white female produced clutches where 50% of the
eggs were GFP+. This result suggested that in this case, the
transgene might be expressed from a single chromosome in all
germ cells, resulting in Mendelian inheritance of the transgene.
To confirm this ratio, this male was used for a second mating,
resulting again in 50% eggs GFP+, supporting the notion of
Mendelian inheritance of the transgene. In the eggs from these
matings, GFP expression was first observed after the mid-
blastula transition (stage 8 of development) consistent with
zygotic expression of the GFP transgene from the male
chromosome.
Fig. 1C depicts the GFP+ F1 transgenic animals at the larval
stage. The animals appear to express GFP uniformly through-
out their body. To examine in more detail whether the GFP
transgene was ubiquitously expressed in the F1 animals various
tissues from an F1 transgenic animal were compared to those
from a white animal of the same age. Strong, ubiquitous GFP
expression was observed in dissected forelimbs, eyes, hearts,
lungs and livers (Fig. 2). Due to our interest in tail regeneration
Fig. 2. GFP fluorescence of major organs and structures in GFP-transgenic
compared to a non-transgenic animal. A and B shows comparison of eyes, C, D
forelimbs, E, F heart, G, H liver, I, J lung. On figures A, C, E, G, I brightfield
and on B, D, F, H, J fluorescent images are shown. Scale bars: A, B, C, D, E, F,
I, J—1 mm, G, H—2 mm.
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resolution in longitudinal cryosections of regenerating tails
(Figs. 3A–C). All tissues including mature and regenerating
spinal cord (SC), the notochord (N), epidermis (E), and the
blastema (B) were uniformly GFP+. By examining cells at high
resolution in the tail fin (Figs. 3D–F) and the tail blastema
(Figs. 3G–I), we could ascertain that all identifiable Ho¨chst-
positive cells were also GFP+. This is particularly clear in the
dorsal tail fin where individual cells are widely separated from
each other and embedded in a dense extracellular matrix (Figs.
3D–F). One exception to the ubiquitous expression was found
in erythrocytes, which did not exhibit GFP fluorescence. A
possible explanation was the quenching of GFP fluorescence
by hemoglobin. Western blots on erythrocytes, however,
showed that erythrocytes contained no detectable GFP protein.
It thus appears that the erythrocyte differentiation program
which involves general transcriptional inhibition (Walmsley et
al., 1991) resulted in suppression of GFP expression.Somite and neural crest contribute to dorsal fin mesenchyme
An animal constitutively expressing GFP is a valuable
tool for analyzing the fate of cells during development and
regeneration by grafting GFP+ cells into unlabeled hosts.
The axolotl is particularly amenable to such an approach as
tissues at all stages (embryonic, larval, juvenile and adult)
engraft from one animal to another extremely well with no
evidence of rejection. Here we have used grafting of GFP+
tissues to study cell fate during embryogenesis and
regeneration. We have focused on the formation of the
dorsal fin during embryogenesis, and the contribution of
blood-derived cells to tail regeneration.
We were interested in the genesis and composition of the
dorsal fin mesenchyme since it is a structure that contributes to
tail regeneration but has been little studied. The fin mesenchyme
is composed of stellate cells embedded in a dense extracellular
matrix (Figs. 3D, E, F). In lower vertebrates, the mesenchyme of
the dorsal fin has been classically assumed to be completely
neural crest-derived (Du Shane, 1935; Raven, 1931, for
schematic, see Tucker and Slack, 2004). To confirm the neural
crest origin of dorsal fin mesenchyme, we replaced trunk neural
folds (8 cases) and cranial folds in addition to trunk neural folds
(2 cases) with GFP+ tissue at stage 16 and examined whether the
dorsal fin was homogeneously labeled (Fig. 4A). Surprisingly,
only the apical portions of the dorsal fin epidermis (stages 40–
41) were GFP+ in all larvae (Fig. 4B). Transverse vibratome
sections (4 individuals) showed that only half of the internal fin
mesenchyme cells were GFP+ and also demonstrated the
complete and specific labeling of the neural crest (Fig. 4C).
These results suggested a possible additional non-neural crest
contribution to the dorsal fin mesenchyme.
A hint to a potential additional source of dorsal fin
mesenchyme came from PAX7 immunohistochemistry of
stages 39–40 animals. In addition to the expected immunos-
taining in the dorsal neural tube (but not in the neural crest nor
neural crest derived structures such as dorsal root ganglia),
PAX7+ cells were observed in the dermatome (Fig. 4D) as well
as some cells in the dorsal fin mesenchyme (Fig. 4D). This
raised the possibility that the dermatome may contribute
mesenchyme to the dorsal fin. To test this, we grafted GFP+
somites into unlabeled hosts at stage 23, well before neural
crest has delaminated and migrated from the neural tube (Fig.
4E). Six out of seven larvae (stage 42) displayed GFP+ cells in
the dorsal fin that sometimes populated even the apical-most
regions of the fin (Figs. 4F, G). Transverse sections revealed
that labeled cells were localized within the mesenchyme (Fig.
4H). As expected, no GFP+ neural crest derivatives were found
in such grafted animals, confirming the specificity of the
transplant. These experiments indicate that dorsal fin mesen-
chyme derives not only from neural crest but also significantly
from the dermatome of the somites.
The contribution of blood cells to tail regeneration
In the following experiments we have used embryonic
transplantation of the blood anlage in order to label blood in
Fig. 3. High-resolution images of GFP fluorescence in cryosections of a regenerating axolotl tail. A regenerating tail of a transgenic fluorescent animal was sectioned
longitudinally and stained with hematoxylin to visualize cells and Ho¨chst to visualize nuclei. (A, B, C) An overview of the tail tissues. sc—spinal cord, n—
notochord, b—blastema, e—epidermis. (D, E, F) Higher magnification view of tail fin cells. Note in hematoxylin and Ho¨chst staining that cells are widely separated
from each other via ECM. All cells are GFP+. (G, H, I) High magnification view of tail blastema cells. All Ho¨chst positive cells are GFP+. (A, D, G) Hematoxylin
staining. (B, E, H) GFP fluorescence from transgenic animal, (C, F, I) overlay of GFP and Hoechst staining. Scale bars: A–C, 200 Am; D–F, 100 Am; G–I, 50 Am.
L. Sobkow et al. / Developmental Biology 290 (2006) 386–397392the developing axolotl larvae, so that we could track the fate
of blood cells during tail regeneration. At stage 18, we
transplanted posterior ventrolateral mesodermal areas (with
overlying epidermis) that will form the ventral blood islands
(Fig. 6A) (Yamada, 1938). In urodeles, this region appears
to be the major source of primitive and definitive
hematopoiesis (Deparis and Jaylet, 1984; Durand et al.,
2002). Of 30 transplants, 3 animals survived to 2 cm long
larval stages where we could follow the course of tail
regeneration. To estimate the percentage of circulating blood
that derived from the GFP graft, we acquired blood samples
from the fully GFP+ germline transgenic animals and
compared it to blood from one of the grafted animals. In
the fully transgenic animals, the erythrocytes were not GFP+
while the non-erythrocytic white blood cells were GFP+
resulting in 3.2% of the circulating blood cells being GFP+
in the fully transgenic animals. When we examined the
blood from one of the grafted animals, 1% of the circulating
blood was GFP+ indicating that we had labeled a significant
proportion of the blood-forming region.
In the grafted animals, we could observe GFP+ cells in
circulating blood (see supplementary movie), as well as
GFP+ cells that were evenly distributed throughout the tail
including the dorsal fin (Figs. 5B and C). The primary cell
type that we observed labeled based on morphology, were
Langerhans cells, which are dendritic cells primarily found
in skin, dermis and lymph nodes. Fig. 5D and E showLangerhans cells with their characteristic cell extensions.
The occurrence of GFP+ cells containing melanin granules
inside their cytoplasm (Fig. 5E) confirms that these are
Langerhans cells that are processing skin antigens (for
review see: Romani et al., 2003). We also observed other
cells with a smaller, rounded to polygonal shape that are
presumably macrophages and leukocytes (Fig. 5F) (Jones
and Corwin, 1996). The presence of Langerhans cells and
macrophages confirms that our transplants label myeloid
lineages.
To determine the contribution of blood cells to regener-
ating tissues we amputated the grafted animals when they
were 2 cm long larvae and allowed the tail to regenerate for
2 weeks (Fig. 6A). Each animal was amputated twice
bringing the total number of observations to six. Tail
amputation caused rapid blood efflux, followed within
several minutes by the formation of a blood clot. After
several hours, the blood clot was enclosed by the wound
epidermis and became part of the blastema. One day post-
amputation, we observed an accumulation of GFP+ cells
close to the amputation plane, either as a result of blood
clotting or due to the migration of GFP+ cells towards the
wound (Fig. 6D). Analysis of the regenerated part of the tail
within the first few days after the lesion shows that the
GFP+ cells that appear in the regenerated tissue are similar
in shape as those in the tail before the regeneration (Sup.
Fig. 2). After 13 days, we observed the same even
Fig. 4. Dual origin of dorsal fin mesenchyme. (A) Schematic showing grafting of GFP+ neural folds to unlabelled hosts in order to investigate the contribution of
neural crest to the dorsal fin. Both cranial and trunk neural folds were labeled. (B) Left side of a white axolotl larva (head to the left, outside the image; stage 40–41)
in which both cranial and trunk neural folds had been replaced with GFP+ neural folds as depicted in A. The label is visible in the apex of the dorsal fin epidermis
(epi), the neural tube (nt) and the middle lateral line nerve (m). Dotted line denotes the level of transverse section shown in C. (C) Transverse vibratome section
through the larva shown in B demonstrates labeling of the apical part of the dorsal fin epidermis (epi). Fin mesenchyme is only sparsely labeled. Higher
magnification views showed approximately 50% of mesenchymal cells labeled (data not shown). Dorsal neural tube (nt) and dorsal root ganglia (drg) are stained. (D)
Anti-PAX7 immunostaining of a transverse paraffin section through the trunk of a larva at stage 39–40. Cells in the dorsal neural tube (nt), dermatome (d) and dorsal
fin mesenchyme (arrow) reacted positively. (E) Grafting of one, left, GFP+ mid-trunk somite to unlabelled host in order to investigate possible contribution of
dermatome cells to dorsal fin mesenchyme. (F) Left side of a white axolotl larva (head to the left, outside the image; stage 40–41) in which one somite had been
replaced with a GFP+ somite as described in E. GFP+ cells, very likely dermatome cells, have left the somite and have migrated into the dorsal fin (df; enlargement
see G). (H) Transverse vibratome section through GFP+ somite revealing migrated GFP+ cells (arrows) within the dorsal fin mesenchyme. Scale bars: B, 250 Am; C,
D, F, H, 100 Am; G, 50 Am.
L. Sobkow et al. / Developmental Biology 290 (2006) 386–397 393distribution of stellate GFP+ cells in the tail, with no
contribution to muscle, cartilage or spinal cord (Fig. 6H, I).
Transverse sections of the regenerated tail confirmed that the
GFP+ cells were not located within muscle, cartilage or
spinal cord tissue (data not shown).Discussion
The ability to produce transgenic axolotls with relative
ease opens up numerous opportunities for producing animals
harboring other cell markers, and for manipulating gene
Fig. 5. Identification of GFP+ blood cell types in the mature tail after grafting GFP+ blood anlage to unlabelled hosts. (A) Schematic showing grafting of GFP+
ventro-lateral tissue at stage 18 to unlabelled hosts and the subsequent pattern of labeling observed in the tail. sc—spinal cord, not—notochord. (B) Fluorescent
image of a tail derived from grafting experiments. (C) Overlay of fluorescence and bright field image. (D) High magnification images of a Langerhans cell in the
dorsal fin; DIC, fluorescence and overlaid images. (E) High-magnification images of a Langerhans cell in the dorsal fin that has taken up melanin granules; DIC,
fluorescence and overlayed images. (F) A second subtype of GFP+ cell that likely represents a macrophage; DIC, fluorescence and overlaid images. Scale bars: B, C,
0.5 mm; D, E, F, 50 Am.
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previously unavailable for this animal. As shown here, an
important aspect is the differing temporal expression profiles
of supposedly constitutive promoters, where expression from
some promoters was lost over time. Further studies will be
needed to determine whether a broad scope of promoters
will be functional in these transgenics. In Xenopus, faithful
tissue specific expression has been observed using promoters
from heterologous species (Hartley et al., 2001). We expect
that such promoters would display the same tissue specific-
ity using the plasmid injection technique.While a broader assessment of the transgenic technique
regarding different promoters and transgenes is necessary
work for the future, an emphasis of the work described here
is the use of the GFP germline transgenic animal for cell
tracking experiments during development and regeneration.
These GFP+ animals are an important tool for embryolog-
ical and regeneration experiments where specific cell or
tissue types need to be followed over long periods of time.
Previously, grafting experiments in axolotls were performed
using either triploid nucleoli or skin pigment which all have
major limitations for analysis (Muneoka et al., 1984;
Fig. 6. Tail amputation of transplanted animals containing GFP+ blood cells. (A) Schematic showing grafting of GFP+ ventro-lateral tissue at stage 18 to unlabelled
hosts and the subsequent pattern of labeling observed in the tail. After reaching a size of 1.5–2 cm animals were subjected to amputation and the contribution of
GFP+ blood and its derivatives to the regenerated tail was followed over 13 days. sc—spinal cord, not – notochord. (B and C) Fluorescent and overlay images of the
tail preamputation. (D and E) Fluorescent and overlay images respectively of the regenerated tail after 1 day. Arrow indicates group of cells embedded in the blood
clot. (F and G) Regenerated tail after 5 days (fluorescence and overlay respectively). GFP+ cells have populated the growing blastema. (H and I) Almost fully
regenerated tail after 13 days, where tail structures including spinal cord, cartilage and muscle have started differentiating. GFP+ cells populated the regenerated tail
with a similar distribution as in the mature tissue. No labeling of muscle fibers, spinal cord or cartilage was observed. Scale bars: B– I, 0.5 mm.
L. Sobkow et al. / Developmental Biology 290 (2006) 386–397 395Pescitelli and Stocum, 1980). The pigmentation grafts are
only useful in grafts containing skin. In the triploid nucleoli
technique only a proportion of the grafted cells contained
three nucleoli and are distinguishable from host cells
(Muneoka et al., 1984). Thus, there is no one-to-one
correspondence of grafted cells to the marker. Secondly,the grafts can only be analyzed upon fixation and
histological analysis. In contrast, GFP+ tissue can be
followed dynamically over time in live animals, and
provides an indelible marker with high spatial resolution,
as shown here in our studies of the dorsal fin, and of blood
during regeneration.
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neural crest cells contribute to the dorsal fin mesenchyme
(Raven, 1931, 1936) and since that time it has been assumed that
neural crest is the sole contributor of mesenchymal cells of the
dorsal fin (see Bodenstein, 1952; Tucker and Slack, 2004). Our
experiments where we transplant complete GFP+ neural folds
indicated that only approximately 50% of the dorsal fin
mesenchyme came from neural crest. Transplantation of GFP+
somites at stage 23 resulted in GFP+ dorsal fin mesenchyme,
indicating that somites (presumably dermatome) also contribute
cells to the dorsal fin mesenchyme. In light of our new findings,
it is possible to re-interpret Bodenstein_s (1952) transplantation
results as being consistent with a dual, neural crest and somite
origin of dorsal fin mesenchyme. Bodenstein transplanted
prospective dorsal fin epidermis laterally over somites at stage
28 and observed the formation of a proper dorsal fin containing
mesenchymal cells. He interpreted this result as indicating that
the neural crest cells that had migrated out of the neural tube and
populated the somites had contributed to the ectopic dorsal fin
mesenchyme. Our somite transplantations were performed well
before neural crest delamination and migration which start in the
anterior trunk at stages 28 and 31, respectively, (Epperlein and
Lofberg, 1990), eliminating the possibility that the somite-
derived fin mesenchyme derives from migrating neural crest. In
a second set of experiments, Bodenstein transplanted dorsal
tissue that included ectoderm and the dorsal half of the neural
tube to the ventral midline in order to observe if these two cell
layers were sufficient to form dorsal fin at an ectopic site. The
ectopic fins that formed were approximately half the size of the
normal fin. When the same dorsal tissue pieces were trans-
planted over somites, full sized fins formed. In a third set of
experiments, when dorsal tissue that included ectoderm, neural
tube and somites were transplanted into the ventral midline, full-
sized fin structures formed. Thus, there was a strong association
of full-sized fin formation with the presence of somites. Our
experiments here indicate that this is due to a major contribution
of somites to dorsal fin mesenchyme.
An important question for the future is whether the
contribution of somites to fin mesenchyme is a feature specific
to urodele amphibians or whether it is generally found in all
lower vertebrates with fins. Smith et al. (1994) used DiI labeling
to characterize the source of fin mesenchyme in zebrafish.
Labeling of neural crest resulted in labeled cells in the dorsal fin
mesenchyme, while labeling of somites did not. At this point, it
is unclear whether this difference to our results is due to a
difference in fin formation between species, or to a technical
difference in the experiments.
Here we have also used embryonic transplantation of GFP+
blood anlage to test the frequency and role of hematopoietic cell
plasticity during tail regeneration. By transplanting the embry-
onic blood-forming region, it is possible to label blood cells,
including the stem cells that give rise to hematopoietic cells. The
axolotl may be an ideal model system for such experiments,
since it is thought that the blood (primitive and definitive)
derives solely or largely from the ventral blood islands rather
than from additional dispersed sites (Durand et al., 2002). Since
the tail is distant from the blood-forming region in the mainbody, a large graft of the ventral body tissue does not interfere
with the specificity of visualizing blood in the tail.
So far, we have observed no contribution of labeled blood
cells to muscle or central nervous system, as was reported in the
mouse (Brazelton et al., 2000; Ferrari et al., 1998; Mezey et al.,
2000). It is difficult to compare quantitatively the frequency of
cell type switching occurring in the mouse with our results.
During the course of our experiments we estimate that we have
tracked in total approximately 600 GFP+ blood-derived cells
(non-circulating), but the total number of stem cells, for
example, that we are tracking is unknown. Comparison of
GFP+ cells in circulating blood in the germline transgenic
animals versus a grafted animal indicated that we had labeled up
to 30% of the total blood cell population.
Our results indicating that blood cells do not contribute
significantly to regenerating tissues is consistent with classical
irradiation experiments performed to determine whether the
regenerating limb blastema arises locally from cells at the
amputation plane, or from distant cells (such as circulating blood
cells) that would home to the injury site (Butler and O’Brien,
1942). In these experiments, a segment of the left hindlimb was
exposed to X-irradiation while the rest of the body was shielded.
When the limb was amputated in the exposed region regener-
ation did not occur, while amputation through the shielded
regions did result in regeneration. These experiments indicated
that the main proportion of cells involved in limb regeneration
arise from the tissue at the amputation plane. Our results coupled
with the Butler and O’Brien work indicate that although
hematopoietic cells may have the potential to form distant cell
types, this plasticity is not utilized or required for regeneration of
complex structures such as the limb or tail. Our results would
thus imply that a more important issue for understanding
regeneration is how tissues at the injury site such as muscle,
dermis and nerve are induced to produce the progenitor cells of
the blastema.
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